Patent details

EP1749531 Title: Use of an oral suspension comprising megestrol acetate for the treatment of bronchial asthma

Basic Information

Publication number:
EP1749531
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP050168756
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Use of an oral suspension comprising megestrol acetate for the treatment of bronchial asthma
French Title of Invention:
Utilisation d'une suspension orale à base d'acétate de mégestrol pour le traitement de l'asthme bronchique
German Title of Invention:
Verwendung von einer oralen Suspension enthaltend Megestrolacetat zur Behandlung von Asthma bronchiale
SPC Number:

Dates

Filing date:
03/08/2005
Grant date:
22/07/2015
EP Publication Date:
22/07/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/02/2007
EP B1 Publication Date:
22/07/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/08/2015
Expiration date:
03/08/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/05/2016
 
 

Name:
Par Pharmaceutical Inc.
Address:
300 Tice Boulevard, Woodcliff Lake, NJ 07677, United States (US)

Inventor

1

Name:
Anker Stefan
Address:
Germany (DE)

2

Name:
Springer Jochen
Address:
Germany (DE)

Classification

Main IPC Class:
A61K 31/57;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages